Novartis Chairman and Chief Executive Daniel Vasella presents the Swiss healthcare group's annual results during a news conference in Basel January 20, 2005. [The world's sixth biggest drugmaker increased 2004 net profit by a lower-than-expected 15 percent to 5.77 billion USD, but added that it expected record sales and profits in 2005.]